A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma.
Saved in:
| Title: | A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma. |
|---|---|
| Authors: | Ng CH; Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia., Obrecht D; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Wells O; Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia., Zapotocky M; Department of Paediatric Haematology and Oncology, Charles University, 2nd Faculty of Medicine and Faculty Hospital Motol, Prague., Sumerauer D; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Paediatric Haematology and Oncology, Charles University, 2nd Faculty of Medicine and Faculty Hospital Motol, Prague., Coltin H; Developmental and Stem Cell Biology, Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Centre, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada., Khuong-Quang DA; Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia., Eisenstat DD; Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia.; Hudson Institute of Medical Research, Melbourne, Australia.; Department of Molecular and Translational Science, Monash University, Melbourne, Australia., Kinross KM; Hudson Institute of Medical Research, Melbourne, Australia.; Australia and New Zealand Children's Haematology/Oncology Group, Melbourne, Australia., White CL; Hudson Institute of Medical Research, Melbourne, Australia.; Department of Molecular and Translational Science, Monash University, Melbourne, Australia.; Victorian Clinical Genetics Services, Melbourne, Australia., Algar EM; Hudson Institute of Medical Research, Melbourne, Australia.; Department of Molecular and Translational Science, Monash University, Melbourne, Australia., Luck A; Michael Rice Cancer Centre, Women's and Children's Hospital; South Australian Health and Medical Research Institute, Adelaide, Australia., Witt H; German Cancer Research Centre, DKFZ, Heidelberg, Germany., Schüller U; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mynarek M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Pietsch T; Department of Neuropathology and DGNN Brain Tumor Reference Center, University Bonn Medical Centre, Germany., Gerber NU; Children's Hospital of Zurich, Switzerland., Benesch M; Medical University of Graz, Austria., Warmuth-Metz M; University Hospital Leipzig, Leipzig, Germany., Kortmann R; University Hospital Leipzig, Leipzig, Germany., Bison B; University of Wuerzburg, Würzburg., Taylor MD; Developmental and Stem Cell Biology, Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada., Rutkowski S; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ) and Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, and Immunology, University Hospital Heidelberg, Heidelberg, Germany., Jones DT; Hopp Children's Cancer Center Heidelberg (KiTZ), Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Gottardo NG; Hudson Institute of Medical Research, Melbourne, Australia.; Perth Children's Hospital, Telethon Kid's Institute, Western Australia, Perth, Australia., von Hoff K; Charité Universitätsmedizin Berlin, Germany., Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ) and Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ramaswamy V; Developmental and Stem Cell Biology, Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.; Departments of Medical Biophysics and Pediatrics, University of Toronto, Toronto, ON, Canada., Hansford JR; Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia.; Hudson Institute of Medical Research, Melbourne, Australia.; Michael Rice Cancer Centre, Women's and Children's Hospital; South Australia Health and Medical Research Institute; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide SA, Australia. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2023 May 12; Vol. 5 (1), pp. vdad057. Date of Electronic Publication: 2023 May 12 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-2498 |
|---|---|
| DOI: | 10.1093/noajnl/vdad057 |
